Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial.
Lancet Oncol. 2014 Oct;15(11):1195-206. doi: 10.1016/S1470-2045(14)70440-1. Epub 2014 Sep 18.
Lancet Oncol. 2014.
PMID: 25242045
Clinical Trial.
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study.
Wålinder G, Genell A, Juliusson G, Svensson R, Santamaria AI, Crafoord J, Carlson K, Knut-Bojanowska D, Veskovski L, Lauri B, Lund J, Turesson I, Hansson M, Blimark CH, Nahi H.
Wålinder G, et al. Among authors: veskovski l.
Cancer Rep (Hoboken). 2022 Nov;5(11):e1614. doi: 10.1002/cnr2.1614. Epub 2022 Mar 3.
Cancer Rep (Hoboken). 2022.
PMID: 35243814
Free PMC article.
Item in Clipboard
Melphalan 100 mg/m2 with stem cell support as first relapse treatment is safe and effective for myeloma patients with long remission after autologous stem cell transplantation.
Blimark C, Veskovski L, Westin J, Rödjer S, Brune M, Hjorth M, Holmberg E, Andersson PO, Mellqvist UH.
Blimark C, et al. Among authors: veskovski l.
Eur J Haematol. 2011 Aug;87(2):117-22. doi: 10.1111/j.1600-0609.2011.01634.x.
Eur J Haematol. 2011.
PMID: 21535157
Item in Clipboard
Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
Veskovski L, Andersson PO, Turesson I, Malmodin D, Pedersen A, Mellqvist UH.
Veskovski L, et al.
Exp Hematol. 2021 May;97:79-88.e8. doi: 10.1016/j.exphem.2021.02.007. Epub 2021 Feb 18.
Exp Hematol. 2021.
PMID: 33609593
Free article.
Item in Clipboard
Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden.
Ali M, Lemonakis K, Wihlborg AK, Veskovski L, Turesson I, Mellqvist UH, Gullberg U, Hansson M, Nilsson B.
Ali M, et al. Among authors: veskovski l.
Blood Cancer J. 2019 Jul 30;9(8):57. doi: 10.1038/s41408-019-0222-8.
Blood Cancer J. 2019.
PMID: 31363079
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite